Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 25, 2026

Top Analyst Reports for SAP, Linde & Parker-Hannifin

View original at finance.yahoo.com
Top Analyst Reports for SAP, Linde & Parker-Hannifin Wednesday, February 25, 2026 The Zacks Research Daily presents the best research output of our analyst team…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Espey shares at 3.09X EV/sales and 12.71X EV/EBITDA, valuation sits above sub-industry averages but below broader market multiples

    80% confidence
  • LIN is not very hopeful about Europe's economy this year

    80% confidence
  • SolarEdge Technologies is likely to benefit from its expanding global presence, though rising U.S. import tariffs continue to create uncertainty for international operations

    80% confidence
  • Teva's newer branded drugs, Austedo, Uzedy and Ajovy are reviving top-line growth, while the recent softness in its generics business is a concern

    80% confidence
  • Espey Manufacturing's gross margin expanded to approximately 35% from approximately 25%, lifting net income to $5 million

    80% confidence
  • SAP forecasts record €10 billion free cash flow in 2026, driven by efficiency, disciplined capital allocation and AI adoption

    80% confidence
  • Linde holds a record-high order book of $10 billion, with projects deemed highly reliable thanks to their fixed-fee contracts and the company's strong track record of successful execution

    80% confidence
  • Espey Manufacturing has rising contract liabilities ($26.3 million) alongside higher inventories suggesting customers are partially funding working capital

    80% confidence
  • Weakness in the transportation market due to lower demand for automotive cars is worrisome for Parker-Hannifin

    80% confidence
  • The Win strategy is driving Parker-Hannifin's margins and allowing the company to continue returning value to shareholders

    80% confidence
  • Copart's rising G and A expenditures may weigh on its near-term margins. Also, improvement in safety technology may reduce the frequency of collisions, affecting revenue growth

    80% confidence
  • Haemonetics has ongoing momentum in the Plasma franchise, owing to share gains in NexSys PCS with Persona, yet rising costs from macroeconomic woes is a concern

    80% confidence
  • RingCentral suffers from challenging macroeconomic uncertainty and pricing pressures in the enterprise segment, primarily due to COVID-related contract lapses

    80% confidence
  • Altria is benefiting from robust pricing actions. In the fourth quarter 2025, higher pricing strategies aided revenues across the Smokeable Products and Oral Tobacco categories

    80% confidence
  • Linde has maintained industry-leading operating margins with further improvements expected from cost-control programs and automation

    80% confidence
  • Linde is one of the top players in the industrial gas business, known for its steady profit growth, smart use of its money and industry-leading efficiency

    80% confidence
  • SAP is facing cloud backlog pressured by deal mix and longer sales cycles, delaying near-term recognition

    80% confidence
  • Risks for Espey include lower fiscal 2026 order expectations, revenue volatility tied to milestone timing, engineering execution risk, customer concentration (top four approximately 65% of sales), and softer cash conversion

    80% confidence
  • Journal Technologies grew 12% YoY to $15.2 million with expanding pretax income, driven by recurring license, maintenance and e-filing fees from government clients

    80% confidence
  • Parker-Hannifin has been dealing with high costs and expenses, which are likely to affect its margins and profitability

    80% confidence
  • Boston Beer continues to experience soft depletions and shipment volumes. In fourth-quarter 2025, shipment volumes decreased 7.5% year over year while depletions dropped 6%

    80% confidence
  • Weakness in China's manufacturing sector poses risks to Linde

    80% confidence
  • TE Connectivity is benefiting from strong growth in the Industrial Solutions segment driven by strong momentum in Digital Data Networks

    80% confidence
  • Parker-Hannifin's high debt level is an added woe, and given the company's international presence, foreign currency headwinds are concerning

    80% confidence
  • Daily Journal shares trade at 2.57X EV/Sales and 1.6X EV/EBITDA, well below peer and market multiples, near historical medians

    80% confidence
  • Prices for helium are falling at a high single-digit pace due to an oversupply in the market, a trend affecting the global market

    80% confidence
  • Parker-Hannifin is benefiting from steady demand in the commercial and military end markets across both OEM and aftermarket channels within the Aerospace segment

    80% confidence
  • Steady adoption of Business Data Cloud and Business AI innovations is a catalyst for SAP

    80% confidence
  • SAP's performance hinges on strong Cloud ERP growth and uptake of its Rise with SAP and Grow with SAP solutions amid macro and geopolitical tensions

    80% confidence
  • Solid booking momentum sets up SAP for faster top-line growth through 2027

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com